Asking Price:Seeks to raise up to $1 million for up to 25% ownership interest in the company
Gross Income:Growth from $1+ million in 2016 to $9.2 million in 2019
Competition: This business objective is to capitalize on its early entry into this unique market that is currently dominated by the traditional veterinary practices, which has over 67%* of the $15.25 billion animal pharmaceutical industry. The company is currently a predominate provider because it recognized this market early and created the infrastructure and the Customer base years ahead of potential competitors that service this market.
Growth & Expansion:
Total sales for the next 4 years are projected to be: $1.1 million in 2016; $2.6 million in 2017; $5.24 million in 2018; and $9.2 million in 2019. The Company currently has signed contracts with major Supermarket chain pharmacies and independent pharmacies that represent approximately 42,000 locations.
The current animal prescription segment of $7 billion as published by the Pet Age December 2015 identifies an impressive year after year continued growth of over 6% annually for the care of animals. The same publication projects growth to $10 billion by 2017.
Most US States have changed their laws requiring Veterinarians to provide a prescription to the animal owner, thereby freeing up pet owners to fulfill their pet's prescriptions at locations other than their Veterinarian's office. This B2B web business offers the animal owner significant savings and convenience.
Clearly there is also significant potential earnings opportunities and incentives for participating retailers and pharmacies as well.
Support & Training: This is an investment and partnership opportunity. The current owners will remain with the company as CEO and President. Note that projections indicate a 4-year total return of 176% to the investor for its $1 million investment, an average annual ROI of 44%.
Reason for Selling:Owners seek funding and partner for expansion with anticipated explosive growth